ARCH Venture Fund XIII, L.P. - 10%+ Owner at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
LYEL on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by ARCH Venture Fund XIII, L.P. since 10 Jan 2025

Holdings reported by ARCH Venture Fund XIII, L.P. for Lyell Immunopharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 938,438 $375,375 $0.4000 25 Jul 2025 By: ARCH Venture Fund XIII, L.P.

There are no transactions reported by ARCH Venture Fund XIII, L.P. for Lyell Immunopharma, Inc.